# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-25-010051
Filing Date
2025-03-12
Accepted
2025-03-12 16:20:48
Documents
105
Period of Report
2024-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-k.htm iXBRL | 10-K | 2506300
2 |  | ex19.htm | EX-19 | 140639
3 |  | ex23-1.htm | EX-23.1 | 5326
4 |  | ex31-1.htm | EX-31.1 | 16472
5 |  | ex31-2.htm | EX-31.2 | 16288
6 |  | ex32-1.htm | EX-32.1 | 7029
7 |  | ex32-2.htm | EX-32.2 | 7412
8 |  | form10-k_001.jpg | GRAPHIC | 28744
9 |  | form10-k_002.jpg | GRAPHIC | 18398
| Complete submission text file | 0001493152-25-010051.txt |  | 11916301

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
10 | XBRL SCHEMA FILE | erna-20241231.xsd | EX-101.SCH | 78349
11 | XBRL CALCULATION FILE | erna-20241231_cal.xml | EX-101.CAL | 109893
12 | XBRL DEFINITION FILE | erna-20241231_def.xml | EX-101.DEF | 366305
13 | XBRL LABEL FILE | erna-20241231_lab.xml | EX-101.LAB | 700364
14 | XBRL PRESENTATION FILE | erna-20241231_pre.xml | EX-101.PRE | 571453
108 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-k_htm.xml | XML | 1808795

Mailing Address 10531 4S COMMONS DRIVE SUITE 166-550 SAN DIEGO CA 92127
Business Address 1035 CAMBRIDGE STREET SUITE 18A CAMBRIDGE MA 02141 (212) 582-1199
Eterna Therapeutics Inc. (Filer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-11460 | Film No.: 25732023
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)